This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better informed drug policy and action. Adopted unanimously by the agency’s key stakeholders in 2016, the strategy is the result of a year-long, in-depth analysis of the environment in which the EMCDDA operates. This analysis focused, in particular, on customer needs and a critical review of our internal capacity to meet them.

Table of contents

• Foreword
• Background – Towards a long–term strategic approach
• EMCDDA strategic and operational framework
  • EMCDDA mission, vision and values
  • Goals, strategic objectives and business drivers
• EMCDDA strategy to 2025
  • Goal 1: Contribute to a healthier Europe
  • Goal 2: Contribute to a more secure Europe
  • The environment for successful delivery: the EMCDDA’s business drivers
• Roadmap 2020
• Annex 1. At a glance: the EMCDDA’s strategic objectives and accompanying action areas
• Annex 2. At a glance: the EMCDDA’s business drivers and accompanying action areas